Nome Químico: (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate-d3
Sorrisos: O=C(C1=C([2H])C([2H])=C([2H])O1)O[C@@]([C@]([C@@]2([H])C3)(C[C@H](O)[C@](F)([C@]4(C=C5)C)[C@@]2([H])C[C@H](F)C4=CC5=O)C)([C@@H]3C)C(SCF)=O
Inchi: InChI=1S/C22H26F3N3OS.H/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;/h1-2,4-7,16,29H,3,8-15H2;/i10D2,11D2,12D2,13D2;1+1
Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC–NMR spectroscopy and HPLC–MS
Nisha Mistry a , Ismail M. Ismail b , Marco S. Smith c , Jeremy K. Nicholson d , John C. Lindon
Journal of Pharmaceutical and Biomedical Analysis 16 (1997) 697–705